Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Location Based Technologies, Inc. (LBAS) Expanding Industry Presence with Innovative Tracking Solutions

Location Based Technologies designs, develops and sells commercial and consumer wearable global positioning system (GPS) tracking solutions based on worldwide GSM networks. The company markets its consumer products under the PocketFinder brand and its commercial products under the LBT brand. Through these two brands, LBAS allows its customers to accurately track and monitor everything from […]

Synergy Pharmaceuticals, Inc. (SGYP) Preparing to File New Drug Application for Leading Product Candidate

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) is a biopharmaceutical company focused on the development of novel therapies to treat gastrointestinal diseases and disorders. The company’s product pipeline includes two drug candidates currently being studied in four unique indications. Synergy’s leading candidate, plecanatide, is in late-stage clinical trials for the treatment of chronic idiopathic constipation (CIC) and […]

Solitron Devices, Inc. (SODI) Enhancing Shareholder Value alongside Improved Financial Results

Solitron Devices, Inc. (OTCQB: SODI) designs, develops, manufactures and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The majority of the company’s products are custom made pursuant to contracts with clients whose end products are typically sold to the United States government. Solitron also offers a selection of additional […]

International Stem Cell Corp. (ISCO) Prepares to Begin Clinical Study of Novel Parkinson’s Disease Treatment Option

Imagine a world where there is no donor organ shortage, victims of spinal cord injuries can walk and weakened hearts are successfully replaced; this is the future of regenerative medicine, as outlined by the National Institute of Health. To obtain the massive promises of this revolutionary treatment option, however, it is necessary to successfully overcome […]

On the Move Systems, Inc. (OMVS) is “One to Watch”

On the Move Systems specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a […]

Net Element, Inc. (NETE) Reports Pending Acquisition’s New 3-Year Contract with Dating Networks

Earlier this morning, Net Element announced that PayOnline signed a new 3-year contract to process transactions for certain international dating networks, including AnastasiaDate, AmoLatina and AsianDate. Collectively, these networks receive more than 150 million unique visits annually and have more than 4 million registered users that spend more than 360 million hours on the sites […]

Synergy Resources Corp. (SYRG) Building Shareholder Value through Expanding Presence in Denver-Julesburg Basin

Synergy Resources Corp. is a domestic oil and natural gas exploration and production company operating in the Wattenberg Field of the Denver-Julesburg Basin in northeast Colorado. The company operates 308 wells throughout the region, in addition to having an ownership interest in nearly 300 net producing wells. Through these projects, Synergy has access to an […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.